DOI 10.3389/fcell.2026.1831705
Regenerative strategies for surfactant deficiency in neonatal and pediatric lung disease: the role of mesenchymal stem cells and their extracellular vesicles.
Аннотация
INTRODUCTION
Surfactant deficiency underlies several neonatal and pediatric lung diseases, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and genetic surfactant disorders. Although advances in neonatal care and surfactant replacement therapy have improved survival in preterm infants, current treatments mainly provide supportive management and do not fully address mechanisms of lung injury and impaired lung development. Regenerative approaches based on mesenchymal stromal cells (MSCs) and their extracellular vesicles (EVs) have emerged as potential strategies to promote lung repair and restore alveolar homeostasis.
METHODS
This narrative review summarizes experimental and clinical evidence on MSC- and EV-based regenerative strategies for surfactant-related lung diseases. Relevant studies investigating MSCs or MSC-derived EVs in neonatal and pediatric lung injury were identified through searches in PubMed, Scopus and Web of Science and were qualitatively analyzed.
MAIN EVIDENCE: Preclinical studies show that MSCs reduce inflammation, protect type II alveolar epithelial cells and promote alveolar development in models of immature lung injury. These effects are largely mediated by paracrine mechanisms, including the release of MSC-derived EVs, which transfer bioactive molecules to target cells and regulate inflammatory and regenerative pathways. Accordingly, EV-based therapies, as a cell-free derivative of MSCs, reproduce several beneficial effects of MSC transplantation in animal models. Early clinical studies in preterm infants at risk of BPD show encouraging safety profiles, although evidence of long-term efficacy remains limited.
CONCLUSION
MSC- and EV-based regenerative approaches represent promising strategies for surfactant-related lung diseases. Further studies are needed to clarify mechanisms of action and evaluate their efficacy in well-designed clinical trials involving neonatal and pediatric populations.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.